Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on June 10, 2025
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
GlobeNewswire
·
June 10, 2025
LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that it is partnering with the Association of Pulmonary Advanced Practice Providers (APAPP) to bring new educational …
Apothecare and FIKA Cannabis Partner to Deliver Pharmacist-Led Cannabis Consultations
GlobeNewswire
·
June 10, 2025
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Apothecare, Canada’s leading pharmacist-led cannabis consultation service, has partnered with FIKA Cannabis, one of the country’s fastest-growing lifestyle cannabis retailers, to launch professional cannabis …
Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs
GlobeNewswire
·
June 10, 2025
A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care for dogs Ingelheim, Germany, and San Francisco, Calif., June 10, 2025 | Boehringer Ingelheim, a global …
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site
GlobeNewswire
·
June 10, 2025
UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgery CLARITY is a prospective, randomized clinical trial designed to demonstrate …
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
GlobeNewswire
·
June 10, 2025
- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, …
XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology
GlobeNewswire
·
June 10, 2025
Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and Commercialization Agreement with Grifols, a global …
HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration
GlobeNewswire
·
June 10, 2025
Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in their Phase Ib clinical trial of its …
मोटापा-रोधी ओरल दवा कार्यक्रम में RenaissThera ने हासिल की शोध की अहम उपलब्धि
GlobeNewswire
·
June 10, 2025
बेंगलुरु, भारत, June 10, 2025 (GLOBE NEWSWIRE) -- बेंगलुरु स्थित बायोटेक्नोलॉजी कंपनी RenaissThera प्राइवेट लिमिटेड ने अपने मोटापा रोधी दवा कार्यक्रम के तहत ग्लूकोज़-डिपेंडेंट इंस्युलिनोट्रॉपिक पोलिपेप्टाइड रिसेप्टर (GIPR) को लक्ष्य करते हुए एक महत्वपूर्ण …
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
GlobeNewswire
·
June 10, 2025
BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic …
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
GlobeNewswire
·
June 10, 2025
MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge …